Sarah Cannon Research Institute at HealthONE
Sarah Cannon Research Institute at HealthONE Sarah Cannon Research Institute at HealthONE in Denver, Colorado is determined to make a difference in our patients’ lives. As a member of Sarah Cannon Research Institute (SCRI), we are a part of a network that has conducted community-based clinical trials for more than 20 years and has administered more than 170 first-in-man clinical trials to date. Sarah Cannon Research Institute at HealthONE Services and Resources Sarah Cannon Research Institute at HealthONE is part of Sarah Cannon, the global cancer enterprise of HealthONE’s parent company, Hospital Corporation of America (HCA). Together, Sarah Cannon and HealthONE offer integrated cancer services to communities across the greater Denver area, which can be accessed at the HealthONE family of hospitals. Through our partnership, we pair cutting-edge research with world-class cancer services that span the entire cancer care journey from diagnosis through survivorship. • Extensive clinical trials menu Program Growth SCRI’s drug development unit has conducted more than 170 first-in-man clinical trials and experienced an annual average growth rate of 15-20 percent in patient enrollment. We are committed to our partners’ goals, and we tailor our teams and processes to meet them. Senior-level management and clinical staff stay involved throughout our working relationship, ensuring strong science and consistent quality every step of the way. We serve as collaborators and research consultants, and we strive to provide informed scientific insights that contribute to success, discovery, and faster answers. • • • • Expansive clinic with patient lounge area Private treatment room On-site pharmacy for patient convenience Wireless Internet and televisions with wireless headphones SCRI’s Drug Development Program offers sponsors consistent performance and research excellence through: • • • • Strict adherence to eligibility criteria A dedicated pharmacokinetic team Rapid accrual Interactive scientific collaboration Locations providing you state-of-theart care. Learn more at: sarahcannon.com/ locations Nashville Est. 1998 sarahcannonresearch.com/denver Sarasota Est. 2009 Oklahoma City Est. 2009 London Est. 2010 Denver Est. 2014 Sarah Cannon Research Institute at HealthONE We have a fully-staffed nursing and clinical research team, including principal investigators, clinic and research nurses, clinical trial managers, data coordinators, regulatory affairs specialists, pharmacy technicians, and day and evening pharmacokinetic technicians. Gerald S. Falchook MD, MS Director, Drug Development Program at SCRI at HealthONE Gerald Falchook, MD, MS, is the Director of Drug Development at Sarah Cannon Research Institute at HealthONE. Dr. Falchook completed his oncology training at MD Anderson Cancer Center, where he also served as a faculty member for six years, developing investigator-initiated clinical trials, as well as collaborating with pharma/biotech industry partners to bring promising new drugs to cancer patients. Dr. Falchook has been the principal investigator or coinvestigator of more than 160 clinical studies, including the first-in-human studies and regimens that have received FDA approval. His research has been published extensively, with more than 90 publications in peer-reviewed journals, as well as more than 150 abstracts at national and international conferences. Accompanying Staff Lindsay Bramwell RN, ACNS-BC Dave Oeser, PharmD Advanced Practice Nurse, Research Nurse Director of Pharmacy Sue Carlson MLT ASCP Lisa R. Salzman Laboratory Registrar Brian W. Herrick Pete Schlickman, PharmD Clinical Trial Specialist Pharmacist Krista Hodges RN, OCN Jason Sortor, MLS (ASCP) Treatment Nurse Laboratory Yesenia Mastasche Lenora Zancanella, MT (ASCP) Laboratory Laboratory Director above: SCRI at HealthONE Facility Kelly Mozzetta Operations Manager Above all else, we are committed to the improvement of patient outcomes and advancement of medical science through innovation and quality execution of cancer research. sarahcannonresearch.com/denver If you are interested in finding out more information related to our clinical trials, please contact: Sarah Cannon Research Institute at HealthONE 1800 Williams Street, Suite 300 Denver, CO 80218 720.754.2610
© Copyright 2024